Furthermore, CMap (Connectivity map) analysis has identified three potential bioactive small molecule inhibitors (NU-1025, thiamine, vinburnine) for HOXB7 targeted therapy in HNSCC. This evidence concerns the gene HOXB7 and head and neck squamous cell carcinoma.